文献速递围术期管理与 ERAS急腹症与外科感染

一期缝合后局部抗生素预防手术部位感染的荟萃分析

Meta-analysis of randomized and quasi-randomized clinical trials of topical antibiotics after primary closure for the prevention of surgical-site infection.
PubMed 文献 · Br J Surg · 2017-06-28

关于过敏性接触性皮炎的风险,目前无法得出结论。

要点

  • 局部抗生素可能降低一期缝合伤口SSI风险,证据质量中等。
  • 局部抗生素较局部消毒剂也可能降低SSI风险,证据质量中等。
  • 局部抗生素是否增加过敏性接触性皮炎风险尚不明确。

核心结论

  • 与不用局部抗生素相比,局部抗生素可能降低一期愈合伤口的SSI风险。
  • 与局部消毒剂相比,局部抗生素可能降低SSI风险。
  • 无法就局部抗生素是否引起过敏性接触性皮炎得出结论。

研究设计与样本

  • 系统检索Ovid MEDLINE、Ovid Embase、Cochrane Wounds Specialized Register、Central Register of Controlled Trials和EBSCO CINAHL,从建库至2016年5月,无语言、日期或设置限制。
  • 两名作者独立筛选研究、提取数据并评估偏倚风险,在足够同质试验时进行荟萃分析。

临床怎么用

  • 对于一期缝合伤口,可考虑使用局部抗生素以降低SSI风险,但需权衡证据质量及潜在过敏风险。
  • 局部抗生素降低SSI的效果可能优于局部消毒剂,但过敏性接触性皮炎风险尚不明确。

局限性

  • 关于过敏性接触性皮炎的证据质量极低,无法得出可靠结论。
  • 部分分析纳入的试验数量有限,可能存在异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical-site infections (SSIs) increase patient morbidity and costs. The aim was to identify and synthesize all RCTs evaluating the effect of topical antibiotics on SSI in wounds healing by primary intention. METHODS: The search included Ovid MEDLINE, Ovid Embase, the Cochrane Wounds Specialized Register, Central Register of Controlled Trials and EBSCO CINAHL from inception to May 2016. There was no restriction of language, date or setting. Two authors independently selected studies, extracted data and assessed risk of bias. When sufficient numbers of comparable trials were available, data were pooled in meta-analysis. RESULTS: Fourteen RCTs with 6466 participants met the inclusion criteria. Pooling of eight trials (5427 participants) showed that topical antibiotics probably reduced the risk of SSI compared with no topical antibiotic (risk ratio (RR) 0·61, 95 per cent c.i. 0·42 to 0·87; moderate-quality evidence), equating to 20 fewer SSIs per 1000 patients treated. Pooling of three trials (3012 participants) for risk of allergic contact dermatitis found no clear difference between antibiotics and no antibiotic (RR 3·94, 0·46 to 34·00; very low-quality evidence). Pooling of five trials (1299 participants) indicated that topical antibiotics probably reduce the risk of SSI compared with topical antiseptics (RR 0·49, 0·30 to 0·80; moderate-quality evidence); 43 fewer SSIs per 1000 patients treated. Pooling of two trials (541 participants) showed no clear difference in the risk of allergic contact dermatitis with antibiotics or antiseptic agents (RR 0·97, 0·52 to 1·82; very low-quality evidence). CONCLUSION: Topical antibiotics probably prevent SSI compared with no topical antibiotic or antiseptic. No conclusion can be drawn regarding whether they cause allergic contact dermatitis.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Heal CF, Banks JL, Lepper P, et al. Meta-analysis of randomized and quasi-randomized clinical trials of topical antibiotics after primary closure for the prevention of surgical-site infection. Br J Surg. 2017. PMID: 28656693. doi:10.1002/bjs.10588

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。